What it isA cardioselective beta-1 adrenergic antagonist with partial beta-2 agonist and mild vasodilatory activity.
Why this oneUsed outside the US for hypertension and shown to reduce arterial events in vascular Ehlers-Danlos syndrome.
What limits itA P-glycoprotein and OATP substrate whose absorption is reduced by food and by transporter-modulating drugs.
NO BOXED WARNINGS
Principal riskNo FDA boxed warning.
